GYN

UTERINE

  • GOG 0238 - A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients with Pelvic Only Recurrence of Carcinoma of the Uterine Corpus
  • GOG 0275- A Randomized Phase III Study of Methotrexate or Dactinomycin in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia
  • GOG 0277- A Randomized Phase III Study of  Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

ENDOMETRIAL

  • GOG 0258 – A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
  • RTOG 1203- A Randomized Phase III Study of Standard vs. Intensity-Modulated Pelvic Radiation Therapy For Post-Operative Treatment of Endometrial and Cervical Cancer

CERVIX

  • GOG 0263 - Randomized Phase III Clinical Trial of Adjuvant Radiation versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy
  • RTOG 1203- A Randomized Phase III Study of Standard vs. Intensity-Modulated Pelvic Radiation Therapy For Post-Operative Treatment of Endometrial and Cervical Cancer
  • RTOG 0724- A Randomized Phase III Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy (Temporary Closure)
  • GOG 0274- A Randomized Phase III Study of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

OVARIAN/FALLOPIAN TUBE

  • GOG 0273- Prospective Study of Chemotherapy Toxicity in Elderly Women with Stage I-IV Ovarian Epithelial, Primary Peritoneal Cavity or Fallopian Tube Cancer- Only remains open to women 75 years of age or older
  • GOG 0261- A Randomized Phase III Study of Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
  • GOG 0186K- A Randomized Phase II Study of Cabozantinib Versus Weekly Paclitaxel in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
  • GOG 0213- A Randomized Phase III Study of Carboplatin and Paclitaxel (or Gemcitabine) with/or without Bevacizumab followed by Bevacizumab and Secondary Cytoreductuve Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary, and Fallopian Tube Cancer
  • GOG 0264- A Randomized Phase II  Study of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex-Cord Stromal Tumors of the Ovary 

Vulvar

  • GOG 0270- Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

Metastatic

  • RTOG 0631- A Randomized Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis